全球冠狀動脈支架市場（2023-2030）：按產品類型（裸金屬支架（BMS）/藥物釋放型支架（DES））和生物材料（生物材料/聚合物生物材料）分類的規模、佔有率、成長分析和預測

Global Coronary Stent Market Size, Share, Growth Analysis, By Product Type (Bare Metal Stents (BMS), Drug-Eluting Stents (DES)), By Biomaterial(Biomaterials, Polymeric Biomaterials) - Industry Forecast 2023-2030

出版日期: 2023年10月08日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

全球冠狀動脈支架市場規模預計將從2021年的88億美元成長到2022年的90.9億美元，預測期內年複合成長率為3.3%，到2030年將達到117.9億美元。

近年來，全球冠狀動脈支架市場經歷了顯著的成長和進步。推動市場成長的主要因素包括心血管疾病盛行率的增加、老年人口的增加以及微創手術的日益採用。包括冠狀動脈疾病在內的心血管疾病的增加導致對冠狀動脈支架的需求增加。生活方式的改變、久坐的生活方式、不健康的飲食習慣等都會導致這些疾病的發生率增加。此外，老年人更容易患心血管疾病，進一步增加了對冠狀動脈支架的需求。

支架設計的技術進步和創新顯著改善了患者的治療效果和安全性。藥物釋放型支架（DES）和生物可吸收支架的開發降低了血管再阻塞的風險並改善了長期結果。這些進步正在推動從傳統的裸金屬支架向藥物釋放型和生物可吸收支架的轉變，從而推動市場成長。

另一方面，市場也面臨一定的挑戰。主要挑戰之一是與冠狀動脈支架置放術相關的高成本，包括支架本身和植入程序的成本。這可能會限制低收入地區和無力承擔支架的患者採用支架。

本報告調查了全球冠狀動脈支架市場，並提供了市場概況、市場各種影響因素分析、技術和創新趨勢、法律制度、市場規模趨勢和預測，以及各個細分市場和地區的細分。、競爭形勢、主要企業簡介等。

執行摘要
調查方法
母市場分析
- 市場概況
- 市場規模
- 市場動態
  - 促進因素
  - 機會
  - 抑制因素
  - 任務
關鍵市場洞察
- 技術分析
- 價格分析
- 供應鏈分析
- 價值鏈分析
- 市場生態系統
- 智慧財產權分析
- 貿易分析
- 啟動分析
- 原料分析
- 創新矩陣
- 研發線產品分析
- 總體經濟指標
- 重點投資分析
- 關鍵成功因素
- 競爭程度
- 市場動態及展望
  - 市場動態
    - 促進因素
    - 機會
    - 抑制因素
    - 任務
- 法規狀況
- 波特的分析
- Skyquest 對未來顛覆的獨家見解
全球冠狀動脈支架市場：依產品類型
- 裸金屬支架（BMS）
- 藥物釋放型支架（DES）
- 生物可吸收支架（BVS）
全球冠狀動脈支架市場：依生物材料分類
- 市場概況
- 生物材料
- 高分子生物材料
- 天然生物材料
全球冠狀動脈支架市場：按地區
- 市場概況
- 北美洲
- 歐洲
- 亞太地區
- 拉丁美洲
- 中東/非洲
競爭形勢
- 前5名企業對比
- 主要企業市場地位
- 主要企業的招募策略
- 關鍵成功策略
- 近期市集活動
- 主要企業市場佔有率
主要企業簡介
- Abbott Laboratories
- Medtronic plc
- Boston Scientific Corporation
- Terumo Corporation
- B. Braun Melsungen AG
- Johnson & Johnson
- Cook Medical Inc.
- CR Bard, Inc.
- Biosensors International Group, Ltd.
- Meril Life Sciences Pvt. Ltd.
- MicroPort Scientific Corporation
- Biotronik SE & Co. KG
- Stentys SA
- Hexacath
- Translumina GmbH
- Elixir Medical Corporation
- Vascular Concepts
- Alvimedica
- InspireMD Inc.
- Comed BV

簡介目錄

Product Code: SQMIG35A2320

Global Coronary Stent Market size was valued at USD 8.8 Billion in 2021 and is poised to grow from USD 9.09 Billion in 2022 to USD 11.79 Billion by 2030, at a CAGR of 3.3% during the forecast period (2023-2030).

The global coronary stent market has witnessed significant growth and advancements in recent years. The market growth is primarily driven by factors such as the increasing prevalence of cardiovascular diseases, rising geriatric population, and the growing adoption of minimally invasive procedures. The rise in cardiovascular diseases, including coronary artery disease, has led to a higher demand for coronary stents. Lifestyle changes, sedentary habits, and unhealthy diets contribute to the increasing incidence of these diseases worldwide. Additionally, the aging population is more susceptible to cardiovascular conditions, further fueling the demand for coronary stents. Technological advancements and innovations in stent designs have significantly improved patient outcomes and safety. The development of drug-eluting stents (DES) and bioresorbable stents has reduced the risk of restenosis and improved long-term results. These advancements have led to a shift from traditional bare-metal stents to drug-eluting and bioresorbable stents, driving market growth. However, the coronary stent market faces certain challenges. One of the major challenges is the high cost associated with coronary stent procedures, including the cost of stents themselves and the implantation procedure. This can limit the adoption of stents in lower-income regions or by patients with limited financial resources.

Top-down and bottom-up approaches were used to estimate and validate the size of the global Coronary Stent Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Coronary Stent Market Segmental Analysis

The global coronary stent market is segmented on the basis of product, biomaterial, and region. By product, the market is segmented into Bare Metal Stents (BMS), Drug-Eluting Stents (DES), and Bioresorbable Vascular Scaffold (BVS). By biomaterial, the market is segmented into Biomaterials, Polymeric Biomaterials, and Natural Biomaterials. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Global Coronary Stent Market Dynamics

Drivers of the Global Coronary Stent Market

Increasing Prevalence of Cardiovascular Diseases

The rising incidence of cardiovascular diseases, including coronary artery disease, is a major driver for the global coronary stent market. Lifestyle changes, unhealthy diets, and sedentary lifestyles contribute to the growing burden of cardiovascular diseases globally.

Growing Aging Population

The aging population is more susceptible to cardiovascular conditions, leading to a higher demand for coronary stents. As the global population continues to age, the prevalence of cardiovascular diseases is expected to increase, driving the demand for coronary stents.

Restraints in the Global Coronary Stent Market

Stringent Regulatory Approval Processes

The stringent regulatory approval processes imposed by regulatory authorities can pose challenges for market growth. Manufacturers must comply with safety and efficacy assessments, which can be time-consuming and resource-intensive, delaying the market entry of new products.

Potential Complications

Stent implantation carries certain risks and potential complications, such as stent thrombosis, restenosis, and allergic reactions. These complications may affect patient outcomes and increase concerns among healthcare providers and patients, impacting market growth.

Market Trends of the Global Coronary Stent Key

Shift towards Minimally Invasive Procedures: There is a growing preference for minimally invasive procedures, including percutaneous coronary intervention (PCI), which drives the demand for coronary stents. Minimally invasive procedures offer benefits such as shorter hospital stays, reduced recovery time, and lower risk of complications compared to traditional open-heart surgeries.

Rising Focus on Patient-Specific Stenting: Personalized medicine and the concept of patient-specific stenting are gaining attention. Advanced imaging techniques, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), are used to assess the morphology and dimensions of coronary arteries, allowing for customized stent selection and placement.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Coronary Stent Market by Product Type
- Market Overview
- Bare Metal Stents (BMS)
- Drug-Eluting Stents (DES)
- and Bioresorbable Vascular Scaffold (BVS)
Global Coronary Stent Market by Biomaterial
- Market Overview
- Biomaterials
- Polymeric Biomaterials
- and Natural Biomaterials
Global Coronary Stent Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Abbott Laboratories (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Medtronic plc (Ireland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Boston Scientific Corporation (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Terumo Corporation (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- B. Braun Melsungen AG (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Johnson & Johnson (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Cook Medical Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- C. R. Bard, Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Biosensors International Group, Ltd. (Singapore)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Meril Life Sciences Pvt. Ltd. (India)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- MicroPort Scientific Corporation (China)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Biotronik SE & Co. KG (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Stentys SA (France)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Hexacath (France)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Translumina GmbH (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Elixir Medical Corporation (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Vascular Concepts (India)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Alvimedica (Turkey)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- InspireMD Inc. (US)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Comed B.V. (Netherlands)
Company Overview
Business Segment Overview
Financial Updates
Key Developments